Post by
Hempminister on Dec 16, 2021 12:04pm
Venowave
Toronto, Ontario--(Newsfile Corp. - June 28, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has secured an exclusive US distributor, a Nashville, Tennessee based organization, DME Authority for Therma's patented FDA approved Venowave, a lightweight Deep Vein Thrombosis (DVT) prophylaxis device. The multi-year agreement provides Therma Bright with a $10 Million annual minimum purchase commitment, with the initial signing order of 5,000 units coming at a time when competitive mobile DVT prevention devices of the same product category are scarce, on back-order, or indefinitely unavailable in the US due to chip manufacturer shortages similarly affecting many other major industries. Due to Venowave's composition, manufacturing of the device remains uninterrupted. Venowave is also uniquely designed for the emerging "Hospital to Home" use market, in the front-line battle against blood clot prevention.
Comment by
nrv090909 on Dec 16, 2021 12:27pm
Finally sales and we all know sales = buyouts.